Disposable Sterile Syringes and Needles Market Opportunity,Analytical Insights and Outlook 2021 to 2027 blackseagrain.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from blackseagrain.net Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Sandoz today announced Treprostinil Injection, a generic Remodulin®, is now also available for subcutaneous ("SC") administration to treat.
Provided by GlobeNewswire
May 24, 2021 8:05 PM UTC
MORRISVILLE, N.C., May 24, 2021 (GLOBE NEWSWIRE) Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced that Sandoz Treprostinil Injection, a generic form of Remodulin®, is now also available for subcutaneous (“SC”) administration to treat patients diagnosed with pulmonary arterial hypertension (“PAH”).
Sandoz Treprostinil Injection was the first fully-substitutable AP rated generic version of Remodulin. Both options for intravenous and SC administration of Sandoz generic Treprostinil Injection are now available at the same specialty pharmacy that dispenses the brand name medicine.
On May 21, 2021, Liquidia PAH’s manufacturing partner, Chengdu Shifeng Medical Technologies LTD (“Chengdu”) began selling the RG 3ml Medication Cartridge, which may be used to supply medications to PAH patients. Liquidia had previously announced the FDA’s clearance of Chengdu�